G6PD deficiency has been reported in association with increased cardiovascular disease and there are studies in vitro indicating that G6PD deficiency may have an anti-carcinogenetic effect, and in the literature, reports of a risk reduction in patients deficient for G6PD to develop cancer can be found [55,56]. This evidence concerns the gene G6PD and cardiovascular disorder.